TB Preventive Treatment: the Need for Choice

The progress made in HIV prevention is nothing short of a global success story. It is time that TB caught up to HIV. Medicine is simply too advanced for us to tolerate how one disease can be beaten back yet another continues to flourish. Credit: Jeffrey Moyo/IPS. By Violet ChihotaJOHANNESBURG, Jul 26 2023 (IPS) Before COVID-19 came along, the two most lethal infectious diseases were HIV and tuberculosis (TB). Even though HIV still lingers, with 1.5 million people contracting the infection every year, epidemiologists point to the availability of many HIV prevention options as a primary reason for the decreasing caseload. According to the World Health Organization (WHO), over the past two decades, new HIV infections decreased by 49%, HIV-related deaths decreased by 61% and an estimated 18.6 million lives were saved because of new treatments that minimise the infection and prevent its spread. We have so many options for HIV prevention at our disposal, including the dapivirine vaginal ring, oral Pre-Exposure Prophylaxis (PrEP), harm reduction for people who use drugs, condoms for both men and women, voluntary medical male circumcision and the recently approved long-acting cabotegravir, with other options in development. We have a suite of prevention tools because everyone is different, and people need to be able to choose their methods according to the way they live their lives. We observe a similar abundance of choice within family planning with oral pills, a variety of injectab...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Africa Headlines Health Poverty & SDGs tuberculosis (TB) Source Type: news